Table 1 Demographic characteristics of patients.
T2EL-related re-intervention (n = 42) | non-T2EL (n = 241) | t/χ2/Z | P | |
|---|---|---|---|---|
Age(years) | 73.04 ± 8.35 | 68.17 ± 7.33 | 3.891 | < 0.001 |
Sex(male) | 85.70% | 83.40% | 0.14 | 0.708 |
Smoking | 73.80% | 50.20% | 8.041 | 0.005 |
Hypertension | 73.80% | 46.00% | 11.018 | 0.001 |
Hyperlipidemia | 47.60% | 52.70% | 0.369 | 0.543 |
Diabetes mellitus | 42.80% | 47.30% | 0.284 | 0.594 |
COPD | 26.10% | 36.90% | 1.805 | 0.179 |
Chronic renal insufficiency | 42.80% | 28.20% | 3.625 | 0.057 |
Anticoagulation | 14.29% | 10.37% | 0.561 | 0.454 |
Follow up time(days) | 178(84,446) | 355(162,646) | ||
Stent graft | ||||
Medtronic | 47.62% | 29.87% | ||
Gore | 23.81% | 31.53% | ||
Cook | 19.05% | 11.61% | ||
Domestic brands | 9.52% | 26.97% | ||
